Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS Patient Registry

Kerem Eitan, Viviani Laura, Zolin Anna, MacNeill Stephanie, Hatziagorou Elpis, Ellemunter Helmut, Drevinek Pavel, Gulmans Vincent, Krivec Uros, Olesen Hanne

Source: Eur Respir J 2014; 43: 125-133
Journal Issue: January

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Kerem Eitan, Viviani Laura, Zolin Anna, MacNeill Stephanie, Hatziagorou Elpis, Ellemunter Helmut, Drevinek Pavel, Gulmans Vincent, Krivec Uros, Olesen Hanne. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS Patient Registry. Eur Respir J 2014; 43: 125-133

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of annual FEV1 decline and factors associated with its accelerated deterioration in a cohort of adults with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013

Global Lung Function Initiative equations improve interpretation of FEV1 decline among patients with cystic fibrosis
Source: Eur Respir J 2015; 46: 262-264
Year: 2015


Annual change of LCI among patients with cystic fibrosis
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016

Lung clearance Index changes over time among patients with cystic fibrosis
Source: International Congress 2015 – New findings in paediatric respiratory physiology
Year: 2015


Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry
Source: Eur Respir J , 49 (2) 1601592; DOI: 10.1183/13993003.01592-2016
Year: 2017




Effect of baseline FVC on decline in lung function with nintedanib: Results from the INPULSIS™ trials
Source: International Congress 2014 – Clinical trials in IPF
Year: 2014


Lung Clearance Index (LCI) and FEV1 on the evaluation of the effect of tobramycin solution for inhalation (TIS) among patients with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014


Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF
Source: Eur Respir J 2001; 18: 298-305
Year: 2001



Late Breaking Abstract - Association of lung clearance index with survival in patients with cystic fibrosis
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019



Longitudinal assessment of Lung Clearance Index as a marker of disease progression in a cohort of children with cystic fibrosis and normal spirometry
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020




Evaluation of the pulmonary function of patients with cystic fibrosis aged 3-18 year old by using impulse oscillometry and spirometry
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015

Hyperinflation in adult cystic fibrosis (CF) patients: Clinical and functional correlates
Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies
Year: 2010

National survey of hearing assessment in patients with cystic fibrosis in the UK
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016


Metabolic and respiratory functioning of patients with cystic fibrosis during the years preceding death
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013


Clinical value of lung clearance index (LCI) among patients with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014


Longitudinal decline in FEV1 in an adult non-cystic fibrosis bronchiectasis cohort
Source: Eur Respir J 2007; 30: Suppl. 51, 529s
Year: 2007

Risk of asthma in heterozygous carriers for cystic fibrosis: A meta-analysis
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016


Modelling future trends in cystic fibrosis demography using the French Cystic Fibrosis Registry: update and sensitivity analysis
Source: Eur Respir J, 50 (2) 1700763; 10.1183/13993003.00763-2017
Year: 2017



Small airways dysfunction is associated with poorer control in asthmatics with a preserved FEV1
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014

Predicting five year outcomes in adults with cystic fibrosis: Developing a predictive scoring model
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013